Compare · COO vs WRBY
COO vs WRBY
Side-by-side comparison of The Cooper Companies Inc. (COO) and Warby Parker Inc. (WRBY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both COO and WRBY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- COO is the larger of the two at $19.03B, about 5.6x WRBY ($3.42B).
- Over the past year, COO is down 2.9% and WRBY is up 21.8% - WRBY leads by 24.7 points.
- WRBY has been more active in the news (10 items in the past 4 weeks vs 4 for COO).
- Both have 25 recent analyst ratings on file.
- Company
- The Cooper Companies Inc.
- Warby Parker Inc.
- Price
- $70.60+3.04%
- $27.89+1.01%
- Market cap
- $19.03B
- $3.42B
- 1M return
- +3.98%
- +5.42%
- 1Y return
- -2.88%
- +21.82%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 4
- 10
- Recent ratings
- 25
- 25
The Cooper Companies Inc.
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services for enhancing health of women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, eye care practitioners, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in San Ramon, California.
Warby Parker Inc.
Warby Parker Inc. designs, manufactures, and retails eyewear products for men and women. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as eye exams and vision tests. As of June 30, 2021, it operated 145 retail stores, which included 142 locations in the United States and 3 locations in Canada, as well as online stores. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Latest COO
- SEC Form 4 filed by Director Keel Paul A
- SEC Form 3 filed by new insider Keel Paul A
- CooperSurgical Supports Saving Mothers to Help Advance Global Women’s Health and Raise Awareness
- CooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions Disclosure
- SEC Form 10-Q filed by The Cooper Companies Inc.
- Needham reiterated coverage on Cooper with a new price target
- SEC Form 8-K filed by The Cooper Companies Inc.
- CooperCompanies Announces Second Quarter 2026 Results
- SEC Form SD filed by The Cooper Companies Inc.
- CooperVision Names Muru Annamalai as President, Asia-Pacific
Latest WRBY
- Warby Parker to Announce Second Quarter 2026 Financial Results on August 6, 2026
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 9,200 shares and sold $275,908 worth of shares (9,200 units at $29.99) as part of a pre-agreed trading plan (SEC Form 4)
- Co-Chief Executive Officer Gilboa David Abraham converted options into 54,347 shares and sold $1,621,714 worth of shares (54,347 units at $29.84) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Warby Parker Inc.
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 189,320 shares and sold $6,445,120 worth of shares (217,667 units at $29.61) as part of a pre-agreed trading plan, decreasing direct ownership by 48% to 31,112 units (SEC Form 4)
- Co-Chief Executive Officer Gilboa David Abraham converted options into 213,746 shares and sold $7,191,541 worth of shares (242,221 units at $29.69) as part of a pre-agreed trading plan, decreasing direct ownership by 48% to 31,112 units (SEC Form 4)
- Director Raider Jeffrey Jacob sold $668,700 worth of shares (22,500 units at $29.72) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 435,201 units (SEC Form 4)
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 36,300 shares and sold $1,090,452 worth of shares (36,300 units at $30.04) as part of a pre-agreed trading plan (SEC Form 4)
- BofA Securities initiated coverage on Warby Parker with a new price target
- SEC Form 4 filed by Co-Chief Executive Officer Blumenthal Neil Harris